Literature DB >> 16378050

History and recent advances in coronavirus discovery.

Jeffrey S Kahn1, Kenneth McIntosh.   

Abstract

Human coronaviruses, first characterized in the 1960s, are responsible for a substantial proportion of upper respiratory tract infections in children. Since 2003, at least 5 new human coronaviruses have been identified, including the severe acute respiratory syndrome coronavirus, which caused significant morbidity and mortality. NL63, representing a group of newly identified group I coronaviruses that includes NL and the New Haven coronavirus, has been identified worldwide. These viruses are associated with both upper and lower respiratory tract disease and are likely common human pathogens. The global distribution of a newly identified group II coronavirus, HKU1, has not yet been established. Coronavirology has advanced significantly in the past few years. The SARS epidemic put the animal coronaviruses in the spotlight. The background and history relative to this important and expanding research area are reviewed here.

Entities:  

Mesh:

Year:  2005        PMID: 16378050     DOI: 10.1097/01.inf.0000188166.17324.60

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  158 in total

Review 1.  Potential neurological impact of coronaviruses: implications for the novel SARS-CoV-2.

Authors:  Joy D Iroegbu; Chibuzor W Ifenatuoha; Omamuyovwi M Ijomone
Journal:  Neurol Sci       Date:  2020-05-18       Impact factor: 3.307

2.  Effects of coronavirus infections in children.

Authors:  Nicola Principi; Samantha Bosis; Susanna Esposito
Journal:  Emerg Infect Dis       Date:  2010-02       Impact factor: 6.883

3.  MultiCode-PLx system for multiplexed detection of seventeen respiratory viruses.

Authors:  Frederick S Nolte; David J Marshall; Christopher Rasberry; Sabina Schievelbein; Grier G Banks; Gregory A Storch; Max Q Arens; Richard S Buller; James R Prudent
Journal:  J Clin Microbiol       Date:  2007-06-27       Impact factor: 5.948

4.  Search, Identification, and Design of Effective Antiviral Drugs Against Pandemic Human Coronaviruses.

Authors:  Tianguang Huang; Lin Sun; Dongwei Kang; Vasanthanathan Poongavanam; Xinyong Liu; Peng Zhan; Luis Menéndez-Arias
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 5.  COVID-19, cytokines, inflammation, and spices: How are they related?

Authors:  Ajaikumar B Kunnumakkara; Varsha Rana; Dey Parama; Kishore Banik; Sosmitha Girisa; Sahu Henamayee; Krishan Kumar Thakur; Uma Dutta; Prachi Garodia; Subash C Gupta; Bharat B Aggarwal
Journal:  Life Sci       Date:  2021-02-16       Impact factor: 5.037

Review 6.  Drug repurposing approach to combating coronavirus: Potential drugs and drug targets.

Authors:  Jimin Xu; Yu Xue; Richard Zhou; Pei-Yong Shi; Hongmin Li; Jia Zhou
Journal:  Med Res Rev       Date:  2020-12-05       Impact factor: 12.944

7.  The Evolution of Severe Acute Respiratory Syndrome Coronavirus-2 during Pandemic and Adaptation to the Host.

Authors:  Snawar Hussain; Sahibzada Tasleem Rasool; Shinu Pottathil
Journal:  J Mol Evol       Date:  2021-05-15       Impact factor: 3.973

Review 8.  SARS-CoV-2 mutations: the biological trackway towards viral fitness.

Authors:  Parinita Majumdar; Sougata Niyogi
Journal:  Epidemiol Infect       Date:  2021-04-30       Impact factor: 2.451

Review 9.  SARS-CoV-2 and its new variants: a comprehensive review on nanotechnological application insights into potential approaches.

Authors:  Ramalingam Karthik Raja; Phuong Nguyen-Tri; Govindasamy Balasubramani; Arun Alagarsamy; Selcuk Hazir; Safa Ladhari; Alireza Saidi; Arivalagan Pugazhendhi; Arulandhu Anthoni Samy
Journal:  Appl Nanosci       Date:  2021-06-10       Impact factor: 3.869

Review 10.  Pathogenesis and Management of COVID-19.

Authors:  Khalid O Alfarouk; Sari T S AlHoufie; Samrein B M Ahmed; Mona Shabana; Ahmed Ahmed; Saad S Alqahtani; Ali S Alqahtani; Ali M Alqahtani; AbdelRahman M Ramadan; Mohamed E Ahmed; Heyam S Ali; Adil Bashir; Jesus Devesa; Rosa A Cardone; Muntaser E Ibrahim; Laurent Schwartz; Stephan J Reshkin
Journal:  J Xenobiot       Date:  2021-05-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.